St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
Destiny Hinton
Destiny Hinton is a communications intern in the Department of Communications & Scientific and Medical Content Outreach at St. Jude Children’s Research Hospital.
Stories by Destiny Hinton
Central line infections: How ETHEL helped us to bust a myth
A simple line drawing helped uncover something unexpected about central line infections. Read how it will save lives.
New studies raise warnings with CRISPR-Cas9, but there's more to the story
Recent studies highlight efficacy and safety issues of CRISPR. While the results are important, read why we should wait before drawing conclusions.
All in the family: How 59,000 volunteers and a team of scientists helped uncover six inherited gene mutations for medulloblastoma
There were 110 suspect genes. We found the six that could lead to childhood brain tumors.
New discoveries are simply that and must withstand the test of time
You really trust the ‘latest and greatest?’ Over-hyped scientific discoveries that haven’t been thoroughly tested create false hope for cures.
Continuing medical education is a vital part of translating research to patient care
Continuing medical education at St. Jude means our physicians are always in school.
Statistical hypothesis testing: minimize bias and help ensure your results are significant
Don’t fall for the trap: Follow these 4 steps to help ensure your experimental results are statistically significant.
4 tips for having difficult conversations with kids who have life-threatening conditions
Prepare a child with a life-threatening condition on what to expect — have that difficult talk with them. Read advice from St. Jude clinical psychologist, Niki Jurbergs, PhD, on how to have that difficult conversation.
Hydroxyurea: How much is too much? Sickle cell study reveals individualized dosage leads to decreased hospitalizations
Federally-funded study of hydroxyurea shows that a long-held medication convention isn’t best for pediatric sickle cell patients.
When pain is the real deal
Read how St. Jude is working toward easing the pain of chronic illness and treatment in its pediatric patients.
St. Jude scientists discover effective combination therapy for treatment of drug-resistant leukemia
A drug used to treat malaria was found to hold the key to unlocking the treatment of a rare leukemia.